Found: 11
Select item for more details and to access through your institution.
Real‐world evidence and biomarkers in allergic diseases.
- Published in:
- Clinical & Experimental Allergy, 2024, v. 54, n. 4, p. 238, doi. 10.1111/cea.14480
- By:
- Publication type:
- Article
Plant‐produced Der p 2‐bearing bioparticles activate Th1/Treg‐related activation patterns in dendritic cells irrespective of the allergic background.
- Published in:
- Clinical & Experimental Allergy, 2024, v. 54, n. 4, p. 300, doi. 10.1111/cea.14456
- By:
- Publication type:
- Article
Ocular surface disease in moderate‐to‐severe atopic dermatitis patients and the effect of biological therapy.
- Published in:
- Clinical & Experimental Allergy, 2024, v. 54, n. 4, p. 241, doi. 10.1111/cea.14461
- By:
- Publication type:
- Article
Easy assessment of the avidity of polyclonal allergen‐specific serum antibodies.
- Published in:
- Clinical & Experimental Allergy, 2024, v. 54, n. 4, p. 278, doi. 10.1111/cea.14448
- By:
- Publication type:
- Article
Protein–Protein interactive networks identified in bronchoalveolar lavage of severe compared to nonsevere asthma.
- Published in:
- Clinical & Experimental Allergy, 2024, v. 54, n. 4, p. 265, doi. 10.1111/cea.14447
- By:
- Publication type:
- Article
Protective effects of allergic diseases in COVID‐19 outcomes: A retrospective cohort study in UK Biobank in the general population and in patients with cancer.
- Published in:
- Clinical & Experimental Allergy, 2024, v. 54, n. 4, p. 297, doi. 10.1111/cea.14445
- By:
- Publication type:
- Article
Long‐term effects of pollen allergoid tyrosine‐adsorbed subcutaneous immunotherapy on allergic rhinitis and asthma.
- Published in:
- Clinical & Experimental Allergy, 2024, v. 54, n. 4, p. 253, doi. 10.1111/cea.14444
- By:
- Publication type:
- Article
Differential dynamics of TARC during JAK‐inhibitor therapy compared to biological therapies targeting type 2 inflammation.
- Published in:
- Clinical & Experimental Allergy, 2024, v. 54, n. 4, p. 294, doi. 10.1111/cea.14442
- By:
- Publication type:
- Article
Children with asthma and eczema carrying filaggrin loss‐of‐function mutations have increased antibiotic use through to adulthood.
- Published in:
- Clinical & Experimental Allergy, 2024, v. 54, n. 4, p. 291, doi. 10.1111/cea.14440
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical & Experimental Allergy, 2024, v. 54, n. 4, p. 235, doi. 10.1111/cea.14337
- Publication type:
- Article
Switching from omalizumab to mepolizumab in severe asthmatics: A post hoc analysis of the RELight study.
- Published in:
- Clinical & Experimental Allergy, 2024, v. 54, n. 4, p. 286, doi. 10.1111/cea.14436
- By:
- Publication type:
- Article